BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1746 related articles for article (PubMed ID: 30482160)

  • 1. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.
    Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V
    BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of neuroblastoma cell lines with uncommon TAZ
    Canzonetta C; Pelosi A; Di Matteo S; Veneziani I; Tumino N; Vacca P; Munari E; Pezzullo M; Theuer C; De Vito R; Pistoia V; Tomao L; Locatelli F; Moretta L; Caruana I; Azzarone B
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33452207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal Stromal Cells in Neuroblastoma: Exploring Crosstalk and Therapeutic Implications.
    Hochheuser C; Windt LJ; Kunze NY; de Vos DL; Tytgat GAM; Voermans C; Timmerman I
    Stem Cells Dev; 2021 Jan; 30(2):59-78. PubMed ID: 33287630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collaboration of cancer-associated fibroblasts and tumour-associated macrophages for neuroblastoma development.
    Hashimoto O; Yoshida M; Koma Y; Yanai T; Hasegawa D; Kosaka Y; Nishimura N; Yokozaki H
    J Pathol; 2016 Oct; 240(2):211-23. PubMed ID: 27425378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation, characterization and neural differentiation potential of amnion derived mesenchymal stem cells.
    Manochantr S; Tantrawatpan C; Kheolamai P; U-pratya Y; Supokawej A; Issaragrisil S
    J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S183-91. PubMed ID: 21294413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-Associated Fibroblasts Share Characteristics and Protumorigenic Activity with Mesenchymal Stromal Cells.
    Borriello L; Nakata R; Sheard MA; Fernandez GE; Sposto R; Malvar J; Blavier L; Shimada H; Asgharzadeh S; Seeger RC; DeClerck YA
    Cancer Res; 2017 Sep; 77(18):5142-5157. PubMed ID: 28687621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of the immunomodulatory capacities of human bone marrow- and adipose tissue-derived mesenchymal stromal cells from the same donor.
    Valencia J; Blanco B; Yáñez R; Vázquez M; Herrero Sánchez C; Fernández-García M; Rodríguez Serrano C; Pescador D; Blanco JF; Hernando-Rodríguez M; Sánchez-Guijo F; Lamana ML; Segovia JC; Vicente Á; Del Cañizo C; Zapata AG
    Cytotherapy; 2016 Oct; 18(10):1297-311. PubMed ID: 27637760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency.
    Starc N; Ingo D; Conforti A; Rossella V; Tomao L; Pitisci A; De Mattia F; Brigida I; Algeri M; Montanari M; Palumbo G; Merli P; Rossi P; Aiuti A; Locatelli F; Bernardo ME
    Sci Rep; 2017 Aug; 7(1):8153. PubMed ID: 28811575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ectopic high expression of transcription factor OCT4 on the "stemness" characteristics of human bone marrow-derived mesenchymal stromal cells.
    Guo X; Tang Y; Zhang P; Li S; Chen Y; Qian B; Shen H; Zhao N
    Stem Cell Res Ther; 2019 Jun; 10(1):160. PubMed ID: 31159871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells.
    Chen MY; Lie PC; Li ZL; Wei X
    Exp Hematol; 2009 May; 37(5):629-40. PubMed ID: 19375653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.
    Wang Q; Yang Q; Wang Z; Tong H; Ma L; Zhang Y; Shan F; Meng Y; Yuan Z
    Hum Vaccin Immunother; 2016; 12(1):85-96. PubMed ID: 26186552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow of neuroblastoma patients shows downregulation of CXCL12 expression and presence of IFN signature.
    Scaruffi P; Morandi F; Gallo F; Stigliani S; Parodi S; Moretti S; Bonassi S; Fardin P; Garaventa A; Zanazzo G; Pistoia V; Tonini GP; Corrias MV
    Pediatr Blood Cancer; 2012 Jul; 59(1):44-51. PubMed ID: 21994039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined use of bone marrow-derived mesenchymal stromal cells (BM-MSCs) and platelet rich plasma (PRP) stimulates proliferation and differentiation of myoblasts in vitro: new therapeutic perspectives for skeletal muscle repair/regeneration.
    Sassoli C; Vallone L; Tani A; Chellini F; Nosi D; Zecchi-Orlandini S
    Cell Tissue Res; 2018 Jun; 372(3):549-570. PubMed ID: 29404727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Primary Bone Marrow Mesenchymal Stromal Cells and Their in vitro Progenies Display Distinct Transcriptional Profile Signatures.
    Ghazanfari R; Zacharaki D; Li H; Ching Lim H; Soneji S; Scheding S
    Sci Rep; 2017 Sep; 7(1):10338. PubMed ID: 28871088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Metastatic Bone Marrow Niche in Neuroblastoma: Altered Phenotype and Function of Mesenchymal Stromal Cells.
    Hochheuser C; van Zogchel LMJ; Kleijer M; Kuijk C; Tol S; van der Schoot CE; Voermans C; Tytgat GAM; Timmerman I
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33147765
    [No Abstract]   [Full Text] [Related]  

  • 16. Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells.
    Djouad F; Bony C; Häupl T; Uzé G; Lahlou N; Louis-Plence P; Apparailly F; Canovas F; Rème T; Sany J; Jorgensen C; Noël D
    Arthritis Res Ther; 2005; 7(6):R1304-15. PubMed ID: 16277684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow from periacetabular osteotomies as a novel source for human mesenchymal stromal cells.
    Handke M; Rakow A; Singer D; Miebach L; Schulze F; Bekeschus S; Schoon J; Wassilew GI
    Stem Cell Res Ther; 2023 Nov; 14(1):315. PubMed ID: 37924114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferative and chondrogenic potential of mesenchymal stromal cells from pluripotent and bone marrow cells.
    Sfougataki I; Varela I; Stefanaki K; Karagiannidou A; Roubelakis MG; Kalodimou V; Papathanasiou I; Traeger-Synodinos J; Kitsiou-Tzeli S; Kanavakis E; Kitra V; Tsezou A; Tzetis M; Goussetis E
    Histol Histopathol; 2020 Dec; 35(12):1415-1426. PubMed ID: 32959885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and Immunomodulatory Effects of Canine Adipose Tissue- and Bone Marrow-Derived Mesenchymal Stromal Cells.
    Russell KA; Chow NH; Dukoff D; Gibson TW; LaMarre J; Betts DH; Koch TG
    PLoS One; 2016; 11(12):e0167442. PubMed ID: 27907211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow-derived mesenchymal stem cells promote invasiveness and transendothelial migration of osteosarcoma cells via a mesenchymal to amoeboid transition.
    Pietrovito L; Leo A; Gori V; Lulli M; Parri M; Becherucci V; Piccini L; Bambi F; Taddei ML; Chiarugi P
    Mol Oncol; 2018 May; 12(5):659-676. PubMed ID: 29517849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 88.